Amphastar Pharmaceuticals Other Current Assets

Amphastar Pharmaceuticals (AMPH) currently reports a other current assets of $16M as of June 2026. That compares with $24M in the prior-year period — down 34.1% year over year. Use the charts on this page to explore Amphastar Pharmaceuticals's other current assets history and peer comparisons.

Amphastar Pharmaceuticals's other current assets decreased from $24M to $16M — a 34.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Amphastar Pharmaceuticals reported $16M in other current assets as of June 2026. That compares with $24M in the prior-year period — down 34.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Amphastar Pharmaceuticals, and consider following AMPH for alerts when major investors trade the stock.

Amphastar Pharmaceuticals is classified in the Healthcare sector. On other current assets, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMPH with unrelated industries.